Post-marketing surveillance to monitor the incidence of intussusception after large-scale vaccination with Reassortant Rotavirus Vaccine, Live, Oral, Pentavalent (Vero Cell) (ROTATEQ®) in Chinese infants using the Ningbo Regional Health Information Platform (NRHIP)

02/07/2020
27/02/2024
EU PAS number:
EUPAS35812
Study
Finalised
Documents
Study protocol
Initial protocol
English (739.5 KB - PDF) View document
Study results
Study results
English (1.14 MB - PDF) View document
Study report
Other information